Life sciences industry forecasts significant revenue from connected health within 5 years
Biopharma sees a sixfold surge in market-ready connected health products since 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
biopharma
Plasmagen Biosciences taps into the niche Indian biopharma market with the launch of CSL’s…
Haemocomplettan P will cater to the 1,50,000 cardiac surgeries and over 1,800 liver transplant patients who are at risk of massive…
Ascentage Pharma signs option agreement with Takeda
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few…
Biotech funding set for recovery in 2024: GlobalData
This optimism follows a downturn in private biotech venture financing, where funding in 2023 declined by 43.2 per cent and 52.3…
Science Magazine names Dr Reddy’s among Top 20 employers in pharma globally
Dr Reddy's is in the list for the second year in a row, placed at number 16 in 2023
Top 20 global biopharma cos report marginal growth in market cap during Q3 2023: GlobalData
Out of the top 20 companies, nine saw their market capitalisation surge by more than 10 per cent, with significant gains achieved…
ABB India bags order to automate Reliance Life Sciences’ biopharma facilities
The company did not disclose the value of the order
Takeda India partners with Bal Raksha Bharat for maternal and child health
This initiative will prioritise nutrition outcomes by deepening partnership with the government to strengthen health and ICDS…
In April 2023, the healthcare industry reported 62 deals worth $22.7 bn: GlobalData
VC investments decreased by 45.8 per cent in April 2023, compared to April 2022
HSBC acquisition of SVB UK may result in for new opportunities for biopharma: GlobalData
According to GlobalData’s Pharma Intelligence Center Deals Database, SVB Financial Group and its subsidiaries were involved in…